All In Biotech

Free tool

FAERS Monitor: Oxytocin

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 018248 or its brand name (Oxytocin, Oxytocin). Reports on generic versions are filed under their own applications.

Reports

2,568

Serious

2,294

89% of reports

Hospitalization

795

Death reported

145

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • foetal exposure during pregnancy413
  • maternal exposure during pregnancy398
  • drug ineffective353
  • exposure during pregnancy317
  • premature baby197
  • off label use163
  • hypotension160
  • premature delivery156
  • maternal exposure during delivery112
  • low birth weight baby101
  • drug exposure during pregnancy99
  • postpartum haemorrhage98
  • nausea85
  • dyspnoea82
  • caesarean section77

Reports by year received

View as table
YearReports
200434
200522
200654
200732
200851
200940
201053
201151
201250
201371
201487
201589
2016151
2017124
2018158
2019137
2020193
2021188
2022228
2023266
2024186
2025161
2026140

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,051,591 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
maternal exposure during deliverySignal1121044.5861.4102,648
postpartum haemorrhageSignal98642.7525.257,634
low birth weight babySignal101105.487.010,216
premature deliverySignal15681.069.512,138
caesarean sectionSignal7754.543.73,966
premature babySignal19754.047.210,134
exposure during pregnancySignal31742.037.912,614
foetal exposure during pregnancySignal41341.838.316,395
maternal exposure during pregnancySignal39836.733.613,796
drug exposure during pregnancySignal9923.919.72,148
hypotensionSignal1606.55.6751
drug ineffectiveSignal3532.22.0243
off label use1631.51.330
dyspnoea821.21.02
nausea850.90.71

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.